I’d buy these two FTSE 100 stocks for my Stocks & Shares ISA today

I’d buy these two FTSE 100 shares for very different reasons. Between them, I see a combination of dividends and growth potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Today I’m looking at two FTSE 100 stocks whose fortunes have been very different during the Covid-19 crisis. Melrose (LSE: MRO) is one, and at one point during the stock market crash its shares lost nearly 70% of their value. That’s recovered to only around 50% now.

Melrose buys up what it sees as undervalued companies, specialising in engineering and manufacturing. It then works on turning them around, and sells at a hopefully-much-improved valuation. The firm’s hostile takeover of GKN in 2018 is a good example of what it does.

The FTSE 100 industrial sector’s troubles have hit Melrose. But things are looking up as the share price picked up 10% on Thursday. For the six months to 30 June, the company reported a pre-tax loss of £685m. But it puts the adjusted pre-tax loss figure at just £40m (from a positive adjusted operating profit of £56m).

Balance sheet

Considering the nature of the business, short-term profit figures don’t really show the big picture. I’m more interested in how Melrose’s debt situation looks during these hard times. And I find it reassuring. At the interim stage, net debt stood at £3,399m, only a little above December 2019’s level of £3,283m. Cash generation has been healthy too, with £213m in adjusted free cash flow.

As long as Melrose can make it through the Footsie downturn, which I’m convinced it can, I see a long-term buying opportunity here. Chairman Justin Dowley said: “Crucially, we own good businesses with significant improvement opportunities.”

In addition, with so many companies valued so lowly right now, there must be some tasty acquisition opportunities for Melrose too.

FTSE 100 safety

Speaking of acquisitions, my second pick today has just completed one. It’s Bunzl (LSE: BNZL), which counts food packaging, cleaning and hygiene supplies, personal protective equipment, and healthcare consumables among among the products it supplies.

That’s nicely defensive anyway. And demand for hygiene and healthcare supplies has given the firm a boost during the pandemic. The share price dipped along with the rest at the start of the crash. But it’s steadily recovered, and we’re now looking at a gain of 15% so far in 2020 — something that very few Footsie companies have managed.

In its latest update, the firm tells us it has “completed the acquisition of MCR Safety, a distributor of a variety of largely own brand personal protection equipment and other safety products based in the US.”

That’s sounds like a company that fits well with Bunzl’s wider business, and it’s got to be a good move for the long term.

Cash generation

Looking back at Bunzl’s interim figures from August, profit is increasing nicely. Adjusted pre-tax profit and adjusted EPS both rose 16%. And in these days when FTSE 100 dividends have been trashed, Bunzl maintained its interim payout. And how lovely it was to see the firm announce “the reinstatement of the 2019 final dividend of 35.8p per share as an additional interim dividend.”

Bunzl has raised its dividend for 27 years in a row now.

So we’re looking at one cash cow with what I see as a very safe and defensive future. And one recovery candidate that remains strong despite its share price slump. Two very different companies, and two I’d buy for very different reasons.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has recommended Melrose. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »